Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

Today, 8:41 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5)

ACAD

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 8:41 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

6 minute read

The Daily Biotech Pulse: Pfizer’s Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings

By Shanthi Rexaline

Today, 8:41 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3)

ABSI

2 minute read

Aridis Pharmaceuticals Announces $25M Registered Direct Offering Priced At A Premium To Market; 4.947M Shares At $5.053/Share

By Bill Haddad

Today, 8:41 AM

Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced that it has entered

ARDS

5 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:41 AM

Gainers

ABSI

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 8:41 AM

Gainers

ARDS

1 minute read

HC Wainwright & Co. Maintains Buy on Aridis Pharmaceuticals, Raises Price Target to $19

By Benzinga Newsdesk

Today, 8:41 AM

HC Wainwright & Co. analyst Vernon Bernardino maintains Aridis Pharmaceuticals (NASDAQ:ARDS) with a Buy and raises the price target from $11 to $19.

ARDS

4 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:41 AM

Gainers

AEHR

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 8:41 AM

AEMD

1 minute read

Aridis In-Licenses Pneumonia Candidate From AstraZeneca

By Vandana Singh

Today, 8:41 AM

Aridis Pharmaceuticals Inc (NASDAQ:ARDS) has entered into an exclusive, worldwide licensing agreement with AstraZeneca plc (NASDAQ:AZN) to in-license the late-stage monoclonal antibody…

ARDS